|
⚲
|
| Transengen Inc | |
|---|---|
| Firm | |
| Fund # | |
| CIK # | 0001401509 |
| Sale | 2009-04-15 ($4.0 M Offered, $2.0 M Sold) |
| Fund | |
| Phone | 2038450551 |
| Address | 15 Oakwood Avenue Norwalk, 06850 |
| Source | [EDGAR] |
| Fund AUM and Sold ($k) |
|---|
| Fund Details | |
|---|---|
| Director | |
| Custodian | |
| Auditor | |
| Marketer | |
| Broker | |
| Jurisdiction |
| Directors | 2011 - 2025 |
|---|---|
| Roy Trice Jr | |
| Anthony Francoline | |
| Randall Schmidt | |
| Gregory Morris | |
| Athanasios Hasiotis |
| Comparable Firms | State | AUM ($B) |
|---|---|---|
|
Kang JeenJoo
✚
|
0.0 | |
|
Kann Fabio
✚
|
0.0 | |
|
Kantowitz Ronald L
✚
|
0.0 | |
|
Kantum Pharma, Inc.
✚
|
0.0 | |
|
Kanuth Robert
✚
|
0.0 | |
|
Kapadia Aman
✚
|
0.0 | |
|
Kaplan Multifamily Partners V, LP
✚
|
0.0 | |
|
Kaplan Philip N
✚
|
0.0 | |
|
Kapoor Kaumudi Kay
✚
|
0.0 | |
|
Kane Kevin James
✚
|
0.0 |